TRVI · CIK 0001563880 · operating
Trevi Therapeutics, Inc. (TRVI) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.6 billion, Trevi Therapeutics, Inc. is a small-cap company. The stock currently trades at $12.57, up 5.45% today, with a 52-week range of $4.22–$14.39.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.47 | $-0.47 | -62.1% | |
| 2023 | $-0.29 | $-0.29 | +35.6% | |
| 2022 | $-0.45 | $-0.45 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-18 | 0000950170-25-041194 | SEC ↗ |
| 2023-12-31 | 2024-03-20 | 0000950170-24-034167 | SEC ↗ |
| 2022-12-31 | 2023-03-16 | 0000950170-23-008472 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0001564590-22-010875 | SEC ↗ |
| 2020-12-31 | 2021-03-25 | 0001564590-21-015506 | SEC ↗ |
| 2019-12-31 | 2020-03-16 | 0001564590-20-010996 | SEC ↗ |